Elizabeth C. Page

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.

Journal: Hereditary cancer in clinical practice

Published: April 01, 2026

Characterising Hepatitis D Virus in the UK From 2011 to 2021.

Characterising Hepatitis D Virus in the UK From 2011 to 2021.

Journal: Journal of viral hepatitis

Published: March 20, 2026

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.

Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.

Journal: Genome medicine

Published: July 29, 2025

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.

Journal: The New England journal of medicine

Published: April 11, 2025

Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers.

Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers.

Journal: British journal of cancer

Published: September 04, 2024

The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.

The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.

Journal: BJU international

Published: June 05, 2024

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.

Journal: BJUI compass

Published: January 07, 2022

Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.

Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.

Journal: Current genetic medicine reports

Published: July 12, 2021

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

Journal: The Lancet. Oncology

Published: July 02, 2021

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: July 07, 2020

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: May 15, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026